SCHEMBL19905053

SCHEMBL19905053

CNC(=O)c1ccnc2c(CCNc3cc(-c4ccc(NC(C)=O)cc4)ncn3)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
MOK Q9UQ07 6/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
CYP2D6 P10635 2/20 0.38
ALOX15 P16050 2/20 0.38
CYP2C9 P11712 1/20 0.38
HSD17B10 Q99714 1/20 0.37
JAK2 O60674 1/20 0.37
PIP4K2C Q8TBX8 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PDE10A Q9Y233 1/20 0.37
SMO Q99835 1/20 0.37
KDR P35968 1/20 0.37
SLC40A1 Q9NP59 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19355266 0.90 CYP1A2 (0.43) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355476 0.90 FAAH (0.42) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355128 0.90 CYP1A2 (0.41) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355460 0.90 CYP1A2 (0.44) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355473 0.88 CYP1A2 (0.43) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355520 0.87 SLC40A1 (0.42) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355284 0.87 CYP1A2 (0.50) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355281 0.86 CYP1A2 (0.45) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19905163 0.86 SLC40A1 (0.42) USP2CYP1A2CYP3A4CYP2C19CLK4
SCHEMBL19355399 0.86 CYP1A2 (0.42) USP2CYP1A2CYP3A4CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057959-B1 DNA-PK INHIBITORS VERTEX PHARMA (US) 2018-02-28 EP disclosed